Semaglutide and tirzepatide are FDA-approved with extensive clinical trial data showing average 15-20% body weight loss, improvements in cardiovascular health markers, reduction in obesity-related disease risk, and excellent safety profile with proper medical supervision
Oral or Gastric Delivery (Experimental) A subset of gastrointestinal studies has explored oral or gastric administration, primarily for research focused on mucosal integrity, inflammation, or protection of the stomach lining
As a busy man, we know your time is limited
The success of this approach depends on the precise engineering of receptor selectivity, potency ratios, and pharmacokinetics to maximize efficacy while minimizing adverse events
[1] [2] It is given as a once-weekly subcutaneous injection
How Brello Health Works The Brello Health process mirrors most telehealth weight-loss platforms and takes only a few steps from signup to delivery